Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1349 |
|---|---|
| Identifier | NCT04630028 |
| Trial Title | A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Ustekinumab Dose Based on BSA and Body Weight|DRUG: Matching Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Wilmington |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-03-17 |
|---|---|
| Primary Completion Date | 2025-07-24 |
| Completion Date | 2025-11-07 |